Cargando…

Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3

Glioblastomas remain the deadliest brain tumour, with a dismal ∼12–16-month survival from diagnosis. Therefore, identification of new diagnostic, prognostic and therapeutic tools to tackle glioblastomas is urgently needed. Emerging evidence indicates that the cellular machinery controlling the splic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuentes-Fayos, Antonio C, Vázquez-Borrego, Mari C, Jiménez-Vacas, Juan M, Bejarano, Leire, Pedraza-Arévalo, Sergio, L.-López, Fernando, Blanco-Acevedo, Cristóbal, Sánchez-Sánchez, Rafael, Reyes, Oscar, Ventura, Sebastián, Solivera, Juan, Breunig, Joshua J, Blasco, María A, Gahete, Manuel D, Castaño, Justo P, Luque, Raúl M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904102/ https://www.ncbi.nlm.nih.gov/pubmed/33141183 http://dx.doi.org/10.1093/brain/awaa273

Ejemplares similares

SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2022)

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2020)

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
por: Vázquez-Borrego, Mari C., et al.
Publicado: (2019)

THU080 Splicing Machinery Dysregulation As A Source Of Novel Diagnostic, Prognostic And Therapeutic Targets In Craniopharyngiomas
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2023)

Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2022)

Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2023)

THU550 The Splicing Factor SRSF6 Regulates Androgen Receptor Activity And Represents A Potential Therapeutic Target In Prostate Cancer
por: Luque, Raul M, et al.
Publicado: (2023)

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery
por: Blázquez-Encinas, Ricardo, et al.
Publicado: (2023)

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
por: Alors-Perez, Emilia, et al.
Publicado: (2021)

Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors
por: Herrera-Martínez, Aura D., et al.
Publicado: (2018)

SUN-LB056 The Pharmacological Blockade of the Splicing Factor SF3B1 Exerts Antitumor Actions in Different Endocrine-Related Cancers
por: Gahete, Manuel, et al.
Publicado: (2019)

Dietary Intervention Modulates the Expression of Splicing Machinery in Cardiovascular Patients at High Risk of Type 2 Diabetes Development: From the CORDIOPREV Study
por: del Río-Moreno, Mercedes, et al.
Publicado: (2020)

Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes: From the CORDIOPREV Study
por: Gahete, Manuel D., et al.
Publicado: (2018)

Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer
por: Gómez-Gómez, Enrique, et al.
Publicado: (2019)

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
por: López-Cánovas, Juan L., et al.
Publicado: (2023)

Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin
por: Sáez-Martínez, Prudencio, et al.
Publicado: (2022)

Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer
por: Sáez-Martínez, Prudencio, et al.
Publicado: (2020)

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2022)

Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas
por: Alhambra-Expósito, María R., et al.
Publicado: (2018)

Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST(5)) in pituitary and pancreatic neuroendocrine tumors
por: Pedraza‐Arevalo, Sergio, et al.
Publicado: (2021)

How Parkinsonian Toxins Dysregulate the Autophagy Machinery
por: Dagda, Ruben K., et al.
Publicado: (2013)

Measles Fusion Machinery Is Dysregulated in Neuropathogenic Variants
por: Jurgens, Eric M., et al.
Publicado: (2015)

Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells
por: León-González, Antonio J., et al.
Publicado: (2021)

Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2019)

Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
por: Gautrey, Hannah L., et al.
Publicado: (2012)

A novel human tumoroid 3D model of sustained ACTH-secreting cell cultures to study critically needed therapies for Cushing's disease
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2021)

Role of autophagy machinery dysregulation in bacterial chondronecrosis with osteomyelitis
por: Ramser, Alison, et al.
Publicado: (2022)

Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1
por: L‐López, Fernando, et al.
Publicado: (2017)

A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
por: Gahete, Manuel D., et al.
Publicado: (2011)

Role of Endogenous Cortistatin in the Regulation of Ghrelin System Expression at Pancreatic Level under Normal and Obese Conditions
por: Chanclón, Belén, et al.
Publicado: (2013)

SRSF7 and SRSF3 depend on RNA sequencing motifs and secondary structures to regulate Microprocessor
por: Le, Minh Ngoc, et al.
Publicado: (2023)

Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
por: Bejarano, Leire, et al.
Publicado: (2019)

Oncogenic SRSF3 in health and diseases
por: Jia, Rong, et al.
Publicado: (2023)

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
por: Hormaechea-Agulla, Daniel, et al.
Publicado: (2017)

The SRSF4–GAS5-Glucocorticoid Receptor Axis Regulates Ventricular Hypertrophy
por: Larrasa-Alonso, Javier, et al.
Publicado: (2021)

Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode
por: Luque, Raúl M., et al.
Publicado: (2016)

Obesity- and gender-dependent role of endogenous somatostatin and cortistatin in the regulation of endocrine and metabolic homeostasis in mice
por: Luque, Raúl M., et al.
Publicado: (2016)

Plasma ghrelin O‐acyltransferase (GOAT) enzyme levels: A novel non‐invasive diagnosis tool for patients with significant prostate cancer
por: Gómez‐Gómez, Enrique, et al.
Publicado: (2018)

Phosphorylation of SRSF1 is modulated by replicational stress
por: Leva, Valentina, et al.
Publicado: (2012)

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
por: Aujla, Amandeep, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h4n0cv909r3ccvjpntukgpceh1